Pulse Biosciences Bought 15,000: What It Means for Investors
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
A brief guide to blue chip alternatives beyond BTC and ETH, highlighting characteristics that define blue chip status and potential rewards.
19,976 articlesA notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Two years after a spouse's death, survivors face a new tax regime. This report outlines crucial 401(k) moves to reduc...
A strategic shift in how the government engages with industry is triggering a market rethink. The administration is t...
Citi sees the recent aerospace pullback as a rare entry point for Boeing, lifting the target to $260 and signaling a ...
Bank of America initiates coverage on Salesforce with an Underperform rating and a $160 price target, highlighting un...
While tech and AI grab headlines, other parts of the market are quietly delivering solid results. This piece explores...
A new study links widening education and earnings gaps between men and women to shifts in dating, engagement, and mar...
Fluence Energy surged nearly 100% in a week on big contract wins and a growing backlog. A quartet of AI-exposed energ...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
If you’re hunting for a stock that could turn a $10,000 stake into a life-changing payout by 2030, you’re not alone. ...
As Congress let enhanced marketplace tax credits lapse, buyers are increasingly eyeing cheaper, alternative health pl...
A 56-year-old chief financial officer debates leaving a high-pressured role for life outside the office, anchored by ...